Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T09:08:24.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:26:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.4.1 to v3.4.2. No other visible changes to study content or layout are evident.
    Difference
    0.0%
    Check dated 2026-02-13T12:26:12.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-06T00:02:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Glossary toggle controls (Show glossary / Hide glossary) were added, and minor wording/capitalization changes were made to update metadata (e.g., Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria, No FEAR Act Data vs No FEAR Act data), plus a revision note 'Revision: v3.4.0'. These changes affect presentation and metadata only and do not alter core study content or functionality.
    Difference
    0.2%
    Check dated 2026-01-22T17:45:14.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page header.
    Difference
    0.0%
    Check dated 2026-01-15T10:39:34.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.